MODVQ · As filed with the SEC
ModivCare cash flow statement, by quarter
The statement as ModivCare presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
(Debtor-in-Possession) Unaudited Condensed Consolidated Statements of Cash Flows · USD thousands
| USD thousands | Q3 2025† 3 months ended Sep 30, 2025 | Q2 2025† 3 months ended Jun 30, 2025 | Q1 2025 3 months ended Mar 31, 2025 | Q4 2024† 3 months ended Dec 31, 2024 | Q3 2024† 3 months ended Sep 30, 2024 | Q2 2024† 3 months ended Jun 30, 2024 | Q1 2024 3 months ended Mar 31, 2024 | Q4 2023† 3 months ended Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|
| Operating activities | ||||||||
| Net loss | (73,131)† | (303,689)† | (50,377) | (23,490)† | (26,604)† | (128,884)† | (22,300) | (5,252)† |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Depreciation | 7,209† | 7,329† | 7,432 | 7,391† | 8,225† | 7,987† | 7,324 | 6,826† |
| Amortization | 16,086† | 16,085† | 16,087 | 19,279† | 19,715† | 19,765† | 19,779 | 19,766† |
| Stock-based compensation | 655† | (430)† | 1,244 | 1,890† | 530† | 2,252† | 2,010 | 2,427† |
| Deferred income taxes | 0† | 0† | (85) | (19,274)† | (12,340)† | 9,365† | (3,778) | (2,417)† |
| Impairment of goodwill | 0† | — | — | 0† | 0† | — | — | 0† |
| Loss on debt extinguishment | — | — | — | 0† | — | — | — | 0† |
| Paid-in-kind interest | (26)† | — | — | — | 0† | — | — | — |
| Amortization of deferred financing costs and debt discount | 3,082† | 5,618† | 5,288 | 1,916† | 1,894† | 1,451† | 1,407 | 1,339† |
| Other assets | — | — | — | — | — | — | — | (6,298)† |
| Equity in net loss of investee | 654† | (1,739)† | 3,295 | 4,285† | 3,670† | 634† | 1,056 | 3,517† |
| Reduction of right-of-use assets | 2,118† | 2,252† | 3,385 | 4,155† | 2,370† | 1,972† | 2,947 | 2,469† |
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable and other receivables | (15,162)† | (19,802)† | (17,382) | 26,561† | (21,376)† | (15,804)† | 3,183 | (19,510)† |
| Contract receivables | (6,833)† | 8,737† | (6,563) | (7,364)† | 48,914† | (24,666)† | 9,280 | (14,685)† |
| Prepaid expenses and other current assets | (7,371)† | (8,831)† | (4,583) | 13,210† | 3,282† | (11,924)† | (2,740) | 11,329† |
| Short-term deposits | (6,700)† | — | — | — | 0† | — | — | — |
| Long-term contract receivables | — | 10,989† | (10,989) | — | — | 13,086† | (19,598) | — |
| Accrued contract payables | 6,072† | (5,326)† | 4,215 | (24,661)† | (39,594)† | (41,504)† | 10,910 | (16,088)† |
| Accounts payable and accrued expenses | 5,557† | 19,482† | (11,133) | 24,845† | 14,924† | (11,982)† | 11,314 | (5,255)† |
| Accrued transportation costs | (23,296)† | 3,268† | (19,890) | 1,722† | (12,750)† | 20,927† | (10,399) | (5,729)† |
| Other assets | — | — | — | — | — | — | 2,162 | — |
| Other long-term liabilities | — | — | — | — | — | — | (2,997) | — |
| Other changes in operating assets and liabilities | (1,819)† | (3,789)† | (2,035) | (420)† | 104† | (3,263)† | — | (4,381)† |
| Net cash used in operating activities | (50,484)† | (22,215)† | (82,091) | 30,045† | 9,273† | (55,286)† | 9,560 | (25,644)† |
| Investing activities | ||||||||
| Purchase of property and equipment | (6,182)† | (6,649)† | (4,061) | (5,349)† | (7,728)† | (6,697)† | (7,856) | (11,145)† |
| Acquisitions, net of cash acquired | — | — | — | — | — | — | — | 0† |
| Net cash used in investing activities | (6,182)† | (6,649)† | (4,061) | (5,349)† | (7,728)† | (6,697)† | (7,856) | (11,145)† |
| Financing activities | ||||||||
| Net proceeds from short-term borrowings | — | — | — | 41,000† | 45,000† | 62,000† | 7,200 | 30,800† |
| Net proceeds from Revolving Credit Facility | 0† | 0† | 0 | — | 45,000† | 62,000† | — | — |
| Issuance of short-term debt | 0† | 0† | 75,000 | — | 0† | 0† | — | — |
| Issuance of long-term debt | 0† | 0† | 30,000 | 0† | 525,000† | 0† | — | 0† |
| Repayment of debt | 0† | (1,312)† | (1,313) | (1,313)† | (508,657)† | 0† | — | 0† |
| Payment of debt issuance costs | 0† | (76)† | (10,711) | (274)† | (24,649)† | (107)† | (756) | 0† |
| Restricted stock surrendered for employee tax payment | — | — | — | (29)† | (435)† | (92)† | (64) | (38)† |
| Proceeds from common stock issued pursuant to stock option exercise | — | — | — | — | — | — | — | 0† |
| Other financing activities | (4)† | 115† | (26) | 743† | 154† | 462† | — | 164† |
| Net cash provided by financing activities | 58,602† | (1,273)† | 92,950 | 39,536† | 36,257† | 62,199† | 6,380 | 30,957† |
| Net change in cash, cash equivalents and restricted cash | 1,936† | (30,137)† | 6,798 | 64,232† | 37,802† | 216† | 8,084 | (5,832)† |
| Cash, cash equivalents and restricted cash at beginning of period | 89,777 | 119,914 | 113,116 | 48,884 | 11,082 | 10,866 | 2,782 | 8,614 |
| Cash, cash equivalents and restricted cash at end of period | 91,713 | 89,777 | 119,914 | 113,116 | 48,884 | 11,082 | 10,866 | 2,782 |
| Supplemental cash flow information | ||||||||
| Cash paid for interest | 18,969† | 14,420† | 31,179 | 31,922† | 9,189† | 31,435† | 4,221 | 31,384† |
| Cash paid for income taxes | 821† | 16,414† | 1,254 | 1,880† | 713† | 6,243† | 270 | 730† |
| Assets acquired under operating leases (non-cash) | 1,063† | 928† | 178 | 913† | 3,553† | 63† | 3,736 | 2,501† |
| Purchase price | — | — | — | — | — | — | — | 0† |
| Cash acquired | — | — | — | — | — | — | — | 0† |
| Acquisitions, net of cash acquired | — | — | — | — | — | — | — | 0† |
| Paid-in-kind debt transaction costs (non-cash) | (36)† | 0† | 7,901 | — | 0† | 0† | — | — |
† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.